Trial · NCT02948842
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Subjects With Complication After Treatment | 84 days | Number of subjects with complication after treatment with clostridium histolyticum collagenase |
| Secondary | Number of Patients Needing Further Intervention for Treatment of Urethral Stricture | 2 years | Further intervention - defined as any medical or surgical intervention for treatment of urethral stricture. |
| Secondary | Number of Subjects With Recurrence of Urethral Stricture | 2 years | Number of subjects with recurrence of urethral stricture |
| Secondary | Change From Baseline and 6 Weeks: American Urology Association Questionnaire Scores | 6 weeks | The American Urology Association questionnaire score is totaled based on 7 questions. Each question asks the subject to rate their symptom on a 5-point scale from "Not at All" (0) to "Almost Always" (5). The total score is based on adding rating marked for each question. The total runs from 0 to 35 points with higher scores indicating more severe symptoms. |
| Secondary | Change From Baseline and 6 Months: American Urology Association Questionnaire Scores | 6 months | The American Urology Association questionnaire score is totaled based on 7 questions. Each question asks the subject to rate their symptom on a 5-point scale from "Not at All" (0) to "Almost Always" (5). The total score is based on adding rating marked for each question. The total runs from 0 to 35 points with higher scores indicating more severe symptoms. |
| Secondary | Change From Baseline and 9 Months: American Urology Association Questionnaire Scores | 9 months | The American Urology Association questionnaire score is totaled based on 7 questions. Each question asks the subject to rate their symptom on a 5-point scale from "Not at All" (0) to "Almost Always" (5). The total score is based on adding rating marked for each question. The total runs from 0 to 35 points with higher scores indicating more severe symptoms. |
| Secondary | Change From Baseline and 12 Months: American Urology Association Questionnaire Scores | 12 months | The American Urology Association questionnaire score is totaled based on 7 questions. Each question asks the subject to rate their symptom on a 5-point scale from "Not at All" (0) to "Almost Always" (5). The total score is based on adding rating marked for each question. The total runs from 0 to 35 points with higher scores indicating more severe symptoms. |
| Secondary | Change From Baseline and 2 Years: American Urology Association Questionnaire Scores | 2 years | The American Urology Association questionnaire score is totaled based on 7 questions. Each question asks the subject to rate their symptom on a 5-point scale from "Not at All" (0) to "Almost Always" (5). The total score is based on adding rating marked for each question. The total runs from 0 to 35 points with higher scores indicating more severe symptoms. |
| Secondary | Time to Urethral Stricture Recurrence | 2 years | |
| Secondary | Time to Additional Intervention for Urethral Stricture | 2 years | |
| Secondary | Change From Baseline and 6 Weeks: Obstructive Voiding Dysfunction (Uroflow) | 6 weeks | Obstructive voiding dysfunction defined as change in uroflow |
| Secondary | Change From Baseline and 6 Months: Obstructive Voiding Dysfunction (Uroflow) | 6 months | Obstructive voiding dysfunction defined as change in uroflow |
| Secondary | Change From Baseline and 9 Months: Obstructive Voiding Dysfunction (Uroflow) | 9 months | Obstructive voiding dysfunction defined as change in uroflow |
| Secondary | Change From Baseline and 12 Months: Obstructive Voiding Dysfunction (Uroflow) | 12 months | Obstructive voiding dysfunction defined as change in uroflow |
| Secondary | Change From Baseline and 18 Months: Obstructive Voiding Dysfunction (Uroflow) | 18 months | Obstructive voiding dysfunction defined as change in uroflow |
| Secondary | Change From Baseline and 2 Years: Obstructive Voiding Dysfunction (Uroflow) | 2 years | Obstructive voiding dysfunction defined as change in uroflow |
| Secondary | Change From Baseline and 6 Weeks: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 6 weeks | Obstructive voiding dysfunction defined as change in post-void residual measurements |
| Secondary | Change From Baseline and 6 Months: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 6 months | Obstructive voiding dysfunction defined as change in post-void residual measurements |
| Secondary | Change From Baseline and 9 Months: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 9 months | Obstructive voiding dysfunction defined as change in post-void residual measurements |
| Secondary | Change From Baseline and 12 Months: Obstructive Voiding Dysfunction (Post-void Residual Measurements) | 12 months | Obstructive voiding dysfunction defined as change in post-void residual measurements |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02948842/registered